Skip to main content
Premium Trial:

Request an Annual Quote

Promega, Puracyp Team on Cell Assay Systems

NEW YORK (GenomeWeb News) – Promega today announced that it has inked an alliance with Puracyp, under which the firms are combining their cell line and assay technologies in an offering to researchers.

The collaboration intends to provide all-inclusive kits for nuclear receptor activation, P450 metabolism, and cellular toxicity research in the drug development process. It combines Puracyp's nuclear receptor expressing cell lines with Promega's assay and detection technologies for bioluminescent reporters, cell viability, and P450 metabolism assays.

The firms said they have already launched cell-based assay systems that include human PXR and human AhR, rodent PXR, and monkey PXR cells.

Terms of the collaboration were not disclosed.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.